Usage: ESTRING is indicated for treating moderate to severe vulvar and vaginal atrophy symptoms associated with menopause.
spinraza
(Nusinersen)
Biogen
Usage: SPINRAZA is indicated for the treatment of spinal muscular atrophy (SMA) in both pediatric and adult patients.
zolgensma
(onasemnogene abeparvovec-xioi)
Novartis Gene Therapies, Inc.
Usage: ZOLGENSMA is a gene therapy for treating pediatric patients under 2 years old with spinal muscular atrophy (SMA) due to bi-allelic mutations in the SMN1 gene. Its safety and effectiveness in advanced SMA and for repeat administration have not been evaluated.